RNDr. Jan Škoda, Ph.D.
Assistant professor, Section of Genetics and Molecular Biology
office: bldg. C13/326
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 8021 |
---|---|
e‑mail: |
social and academic networks: |
---|
Finished procedures
Habilitation procedures | |
---|---|
Applicant's name at procedure initiation | RNDr. Jan Škoda, Ph.D. |
Applicant's workplace at procedure initiation | Faculty of Science |
Procedure field | Molecular Biology and Genetics |
Faculty implementing procedure | Faculty of Science |
Procedure status | appointment to associate professor |
Procedure initiation date | 13 Sep 2024 |
Procedure conclusion date | 1 Jan 2025 |
Habilitation thesis (publicly available part) |
Novel molecular approaches to overcome therapy resistance in pediatric solid tumors
Grounds for withholding the publication license of the habilitation thesis:
The grounds for withholding the publication license of the habilitation thesis or its part are available in Czech only.
|
Habilitation thesis reviewers |
MUDr. Aleš Vícha, Ph.D. (Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University)
doc. Mgr. Karel Souček, Ph.D. (Faculty of Science MU) Dr. Olga Piskareva (RCSI, Anatomy and Regenerative Medicine, Dublin, Ireland) |
Reviewers' thesis reports | Report 1 | Report 2 | Report 3 |
Public lecture | 25 Oct 2024 | Lecture Evaluation |
habilitation board | |
Chair | prof. Mgr. Vítězslav Bryja, Ph.D. (Faculty of Science MU) |
Members |
prof. RNDr. Jan Šmarda, CSc.
(Faculty of Science MU)
doc. MUDr. Eva Froňková, Ph.D. (Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University) doc. RNDr. Daniel Rösel, Ph.D. (BIOCEV, Vestec, Czech Republic) Assoc. Prof. Dr. Frank Westermann (Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany) |
Board decision | Board Decision |
Faculty scientific board session date | 27 Nov 2024 |